See other companies on Welcome to the Jungle
ieso
Digital mental healthcare and therapeutics
- 201-500 employees
- Healthcare
- B2C
- Mental health
- SaaS
- Milton, UK
Jump to section
Company mission
To address the global rise in mental ill health by creating breakthroughs in how mental health is understood and treated, so that people everywhere have the opportunity to feel better.
Our take
It is becoming increasingly urgent that we transform the way mental health is understood and treated in order to produce better outcomes. Ieso is a digital mental healthcare and therapeutics business that develops clinically evidenced assessment and treatment products to treat mental health conditions.
Technology has long served health treatment, from MRI Scanners to X-Rays, but Ieso was an early company to integrate the rising AI and machine learning technology into mental healthcare. With over 700 accredited CBT therapists and having collected over half a million hours of therapy sessions, Ieso’s technology recognises patterns in conditions and treatments which is then used to equip patients with the precise tools to combat their specific condition.
Ieso has been described as the number one UK mental healthcare company and will work to hold this position after recent Series B funding, led by Morningside. This investment will be used to expand operations and develop its autonomous therapy systems.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Up to 5% matched pension contribution
- 25 days holiday per year plus 8 bank holidays, plus 3 extra days for Christmas office closure, and the ability to purchase more
- Death in Service 3x salary
- Discretionary bonus scheme (following successful probation)
- Extensive training and development options
- Five Ways to Thrive Well-being Programme
- Active Sports and Social Clubs
- Flexible benefits package including healthcare cash plan, cycle to work, gym and shopping discounts and much more
Company values
- Audacious - Braking new ground is in our DNA
- Brilliant - Whatever we do, we do it brilliantly
- Compassionate - We act compassionately and keep an open mind
Funding (last 2 of 4 rounds)
Nov 2021
$53m
SERIES B
Oct 2018
$0.6m
GRANT
Total funding: $77.1m
This company has top investors
Leadership
Lesley Gallinger
(CEO, not founder)Previously acted as President and CEO for Elexicon Energy, Chief Strategy and Financial Officer for Electrical Safety Authority, Vice President of Corporate and Regulatory Affairs and CFO for Oakville Hydro Corp, Vice President of Finance and Administration for Swiss Herbal Remedies, Director of Finance for Novartis Consumer Health Canada, and Manager of Finance for Dupont Pharma.